Join the club for FREE to access the whole archive and other member benefits.

Frequency Therapeutics

Company developing drugs that treats degenerative diseases

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.

Visit website:




People at Frequency Therapeutics

Chris Loose

Co-founder and Chief Scientific Officer at Frequency Therapeutics

David Lucchino

Co-founder, President and CEO at Frequency Therapeutics.

Frequency Therapeutics News

Longevity Technology interviews Frequency Tx' CSO about activating innate progenitor cells

Longevity Technology - 01-Nov-2022

Cells are already in the right place, just need the right kick to help repair the body when needed


Hearing loss drug triggers improvements in phase 1/2 trials

FierceBiotech - 09-Apr-2019

Restoring hearing and vision would make many people's lives significantly easier